NCT06647797

Brief Summary

Our novel communication strategy aims to promote HIV testing in Uganda with reassuring messages about the ability to have stable relationships and healthy families with the increased availability of pre-exposure prophylaxis (PrEP). We will evaluate the feasibility and acceptability of this communication strategy among clients and partners within assisted partner notification and antenatal care programs in two hospitals and evaluate preliminary effects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22,359

participants targeted

Target at P75+ for not_applicable hiv

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable hiv

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2023

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

October 16, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 18, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 14, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2025

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

September 22, 2026

Completed
Last Updated

September 22, 2026

Status Verified

August 1, 2026

Enrollment Period

1.5 years

First QC Date

October 16, 2024

Results QC Date

July 1, 2026

Last Update Submit

August 25, 2026

Conditions

Keywords

Antiretroviral medication

Outcome Measures

Primary Outcomes (2)

  • Change in Rate of HIV Testing (Male Partners of Antenatal Care Patients)

    We used register extraction of standard ANC clinic registers to determine testing status of male partners of each patient who had an ANC visit during the baseline and intervention periods. We excluded those indicating the male partner was not recommended for HIV testing (known HIV negative from previous test during this pregnancy; known HIV positive from previous test during this pregnancy; known HIV positive determined prior to first ANC visit; known HIV negative according to test conducted within 4 weeks prior to first ANC visit). Successful testing as a composite outcome included partners who tested for the first time (positive or negative) or completed a re-test following a negative test earlier in the pregnancy (recommended after 3 months).

    7 month baseline period (Sept 2023- March 2024) and 7 month intervention period (Sept 2024- March 2025)

  • Change in Rate of HIV Testing Among Partners of Assisted Partner Notification (APN) Program

    APN partner testing was extracted from standard clinic registers. We excluded partners who were known to be HIV positive or deceased. Our analysis examined the portion of APN partners recommended for testing who presented at the hospital for testing.

    7 month baseline period and 7 month intervention period

Study Arms (2)

Communication intervention "HOPE"

EXPERIMENTAL

* Patient-facing education materials * Provider counseling job aid and training

Behavioral: HOPE Clinical Communication Campaign

Usual care

NO INTERVENTION

Usual care

Interventions

* Patient-facing educational materials * Provider counseling training and job aid

Communication intervention "HOPE"

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Client or partner of client receiving antenatal or assisted partner notification services at one of two study hospitals (Gombe Hospital or Mityana Hospital)

You may not qualify if:

  • Individuals under the age of 18 years (for interviews and surveys only)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Gombe Hospital

Gombe, Uganda

Location

Mityana Hospital

Mityana, Uganda

Location

Limitations and Caveats

Findings are limited to one intervention site and may not reflect how other hospitals or lower-level health centers may experience the intervention. Effectiveness analyses were exploratory in this R34 study, which was not designed to detect main effects.

Results Point of Contact

Title
Emily Hurley
Organization
Children's Mercy

Study Officials

  • Emily Hurley, PhD

    Children's Mercy Kansas City

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Two hospital sites. One randomized to implement the communication intervention, the other continuing with usual care
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctoral Research Faculty

Study Record Dates

First Submitted

October 16, 2024

First Posted

October 18, 2024

Study Start

September 15, 2023

Primary Completion

March 14, 2025

Study Completion

March 14, 2025

Last Updated

September 22, 2026

Results First Posted

September 22, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will share

De-identified dataset and other materials will be made available to individual researchers upon reasonable request.

Locations